Laga Upper Circuit 💐💐Dhamakedaar Quarterly Results🔥🔥Vijay Kedia,Mukul Agrawal bhi hai Invested🥳🥳

요약 보기

결론: 제약사 Neuland Laboratories의 분기 실적이 크게 개선되어 주가가 상한가 근접까지 급등했다는 내용이다. 실적 수치: 총수익은 전년 동기 29,300에서 이번 분기 42,000으로 증가했고, 직전 분기는 36,500이었다. 총비용은 24,000에서 29,900으로 늘었다. 순이익은 전년 동기 3,833에서 이번 분기 8,900으로 두 배 이상 증가했다. 주당순이익(EPS)은 전년 29.8에서 이번 분기 69.2로 상승했다. 주가 및 기업 정보: 실적 발표 당일 주가가 하루 만에 141포인트 급등했고 상한가에 근접했다. 시가총액은 약 5,600억 루피 수준의 소형주로 소개됐다. 투자자 언급: Dolly Khanna, Mukul Mahavir Agarwal, Vijay Kedia 등 유명 투자자들이 이전부터 해당 종목을 보유 중이라고 언급했다. 영상은 이들을 그대로 따라 사지 말고 투자 동향을 참고하며 공부하라고 조언한다. 종목별 방향 및 리스크: 언급된 종목은 Neuland Laboratories 하나이며 방향은 상승으로 제시됐다. 향후 1~3개월 가격 전망이나 구체적 목표가는 제시되지 않았고, 수익성 개선이 비용 관리에 달려 있다는 점이 조건으로 언급됐다.

다듬은 글

※ 자동 자막 원문(다듬기 전)

01. So friends, let's start today's video and today such a tremendous result came of a company, I mean what should I say, I mean the market was open when the results came and the market caught fire, I mean the share ran so fast, I mean the share was about to hit the upper circuit, I mean the rise at 15 came in a single day, almost tremendous results came, I will show you the result once and then I will also tell you the name of the company and will also tell you one special thing about this company, so let's first look at the total income of the company, if we look at the total income, last year in this quarter it was 29300, the income in the previous quarter was 36500 and the income that has been earned in this quarter is 42000, so you can see that yearly and quarterly there has been a very good jump in income, the business has been good, so now we just have to manage the expenses, then the profit will be tremendous if the expenses are managed, so if we look at the total expenses, last year it was 24000 in this quarter The amount which came in the last quarter was 28150 and the expenses which have been incurred in this quarter are 29900, so you can see that the expenses are also a little big but we have to see the net profit, profit for the period, that is, how much money the company earned after all the expenses, if we look at that, it was 3833 in the same quarter last year, it was 3833 and the amount which has come in the last quarter is 622 i.e.

02. 6222 and the profit which has come in this quarter is 8900, that is, there is a massive jump in the profit, if we look at it yearly, it is more than double, that is, the profit has been more than double, if we look at it yearly and quarterly, there has been a huge jump in the profit, so a very good thing can be said for this company, for this share and for those who have invested in it and if we look at its EPS also, we will see the same thing in EPS which was last year, 29.8 in this quarter and 48.5 in the previous quarter and The EPS that has come in this quarter is 69.2, so you can see that there has been tremendous growth in the company, so let me also tell you the name of the company, which company is it, it is a pharma company, which means it is a very small company and if I were to tell you its name, then look at Neuland Laboratories Limited, which means it is a pharma company and a small-cap company, its market cap is around Rs 5,6000 crore and this Neuland Laboratories Limited, the results of this company have been very good and the special thing about this share, this company, which I am going to tell you is that many big investors, big investors, had already bought stock in it, so if we talk about Dolly Khanna ji, she had a stake earlier, so perhaps she did not sell her stake in this quarter, but she had bought it earlier and if we talk about Mukul Mahavir Agarwal, which means he is also a very big investor, he has also invested a good amount in it, even now, so he must have made a good profit today and if we look at it, Vijay Kedia ji, he had also invested in it and is still an investor, he has still invested, you can see that such big investors already have an idea about what kind of results a particular company can give, so for that he had earlier invested in this company and you can see that such excellent results have come, today the company has shown a rise of 141 points in a single day, so we should always keep this in mind that we should not copy them, but where do they go, what are they doing, that is, we should not follow them, I am just saying that we should always keep a little attention on where they invest, where are they going, which sector are they going to, which stock are they going to, we just have to study and see, we should not copy, so this company has given an excellent result, so that's all for today.